Table 1. Evidence that ER stress-induced macrophage (Mφ) apoptosis and defective efferocytic clearance of apoptotic Mφs are important in advanced plaque progression in mouse models of atherosclerosis.
A. Models affecting ER stress-induced Mφ apoptosis | |||
---|---|---|---|
Mouse model | Description of mutation | Weeks on high-fat diet | Effect of mutation on Mφ apoptosis and plaque necrosis in advanced aortic root lesions |
Npc1+/−;Apoe−/−81 | NPC1 is a protein involved in intracellular cholesterol trafficking. The heterozygous mutation results in a partial defect of cholesterol trafficking to the ER, and thus protects the ER from cholesterol-induced ER stress | 18, 25 | ↓ |
Stat1−/− → Ldlr−/−*82 | STAT1 is activated during ER stress and promotes Mφ apoptosis | 10, 12 | ↓ |
Chop−/−;Apoe−/−83 Chop−/−;Ldlr−/−83 | CHOP is induced during ER stress and triggers apoptosis in ER-stressed Mφs | 10, 12 | ↓ |
Insr−/− → Ldlr−/−85 | Mφs lacking insulin receptors, as a model of Mφ insulin resistance, undergo ER stress and are more susceptible to ER stress-induced apoptosis | 8, 12 | ↑ |
Sra−/−;Cd36−/−; Apoe−/−88 | Activation of the type A scavenger receptor (SRA) and CD36 synergize with ER stress to cause apoptosis in Mφs | 12 | ↓ |
p38afl/fl;LysMCre+/−; Apoe−/−89 | ER stress activates p38 in Mφs, which can trigger a compensatory cell survival pathway through activation of Akt | 9 | ↑ |
B. Models affecting efferocytosis | |||
Mouse model | Description of mutation | Weeks on high-fat diet | Effect of mutation on Mφ apoptosis and plaque necrosis in advanced aortic root lesions |
Tg2−/− → Ldlr−/−102 | Transglutaminase 2 mediates recognition of apoptotic cells by efferocytic Mφs | 16 | ↑ |
Mfge8−/− → Ldlr−/−103 | MFG-E8 is a molecule that can bridge apoptotic cells and efferocytes, thus facilitating efferocytosis | 8, 15, 20 | ↑ |
MertkKD;Apoe−/−104, 105 | Mertk is a receptor on efferocytes for apoptotic cells. The KD mutation renders the receptor non-functional | 8, 10, 15, 16 | ↑ |
Gld;Apoe−/−106 | The Gld mutation inactivates the ligand for the Fas receptor. Mice with this mutation acquire an autoimmune syndrome characterized by defective efferocytosis. | 12 | ↑ |
This designation indicates transplantation of bone marrow from mutant mice into lethally irradiated Ldlr−/− mice to create chimeric mice in which only bone marrow-derived cells carry the mutation. Bone marrow from wild-type mice are used for the control arm in these types of studies. For atherosclerosis studies using this method, the major type of lesional cell carrying the mutation is the macrophage.